Side effects
GLP-1 Side Effects by Week: What Labels Say
GLP-1 side effects by week: label dose schedules beside nausea, vomiting and diarrhea rates for the doses tested, plus warning signs that need a doctor.
Guides
Ozempic Nausea: How Long It Lasts
How long does nausea last on Ozempic?
Ozempic nausea has no day count on the label, but the Ozempic prescribing information says that the majority of nausea, vomiting and diarrhea reports occurred during dose escalation. In its type 2 diabetes trials, nausea affected 15.8% of people on 0.5 mg and 20.3% on 1 mg, against 6.1% on placebo.
Feeling sick after a shot or a dose step is a frequently reported reaction in the labels' trials. The labels do not say for how many days, so your prescriber is the one to judge your own case.
In short
- The Ozempic label reports nausea in 15.8% (0.5 mg) and 20.3% (1 mg) of people with type 2 diabetes, against 6.1% on placebo.
- The Ozempic, Wegovy, Mounjaro and Zepbound labels all place most gastrointestinal reports in the dose-escalation period.
- Only the Mounjaro and Zepbound labels say events decreased over time, and none gives a day count.
How common is nausea on Ozempic, Wegovy, Mounjaro and Zepbound?
In the placebo-controlled trials in the four prescribing labels, nausea occurred in 12% to 44% of people on the medicine, and always more often than on placebo. The table sets each label's Ozempic, Wegovy, Mounjaro and Zepbound figures side by side.
| Medicine and trial population | Dose | Nausea | Vomiting | Diarrhea | Placebo (nausea / vomiting / diarrhea) |
|---|---|---|---|---|---|
| Ozempic, type 2 diabetes | 0.5 mg | 15.8% | 5% | 8.5% | 6.1% / 2.3% / 1.9% |
| Ozempic, type 2 diabetes | 1 mg | 20.3% | 9.2% | 8.8% | 6.1% / 2.3% / 1.9% |
| Wegovy, weight management | 2.4 mg | 44% | 24% | 30% | 16% / 6% / 16% |
| Mounjaro, type 2 diabetes | 5 mg | 12% | 5% | 12% | 4% / 2% / 9% |
| Mounjaro, type 2 diabetes | 10 mg | 15% | 5% | 13% | 4% / 2% / 9% |
| Mounjaro, type 2 diabetes | 15 mg | 18% | 9% | 17% | 4% / 2% / 9% |
| Zepbound, weight management | 5 mg | 25% | 8% | 19% | 8% / 2% / 8% |
| Zepbound, weight management | 10 mg | 29% | 11% | 21% | 8% / 2% / 8% |
| Zepbound, weight management | 15 mg | 28% | 13% | 23% | 8% / 2% / 8% |
Trial sizes: Ozempic 262 on placebo, 260 on 0.5 mg and 261 on 1 mg. Wegovy 1,261 on placebo and 2,116 on 2.4 mg. Mounjaro 235 on placebo and 237, 240 and 241 by dose. Zepbound 958 on placebo and 630, 948 and 941 by dose. Each label states its trial durations.
Read each row against its own placebo. Ozempic 1 mg is 20.3 − 6.1 = 14.2 points above placebo, and Wegovy is 44 − 16 = 28 points above. The populations differ, so the table is not a ranking. The choice of medicine belongs to you and your prescriber.
Why does Ozempic cause nausea?
The Ozempic label does not explain why nausea happens in some people and not others. What the label shows is when reports cluster: during dose escalation.
The semaglutide label gives a half-life of approximately 1 week. As the article's own estimate from that figure, a dose leaves the body slowly. This is an inference, not a label finding about nausea. For the longer story of how a dose lingers, read how long Ozempic stays in your system. To see roughly where that sits after a shot, you can estimate how much semaglutide or tirzepatide is likely still active after a dose. It is an estimate, not a lab value, and it suggests no dose.
Some things are not known from these sources. The labels report how often nausea happens, not why one person feels it strongly and another barely at all. They also give no figure for how long a single episode lasts.
Does Ozempic nausea get better after a dose increase?
Ozempic nausea was reported mostly during dose escalation, according to the Ozempic label, and the Mounjaro and Zepbound labels add that events decreased over time. The Wegovy label says gastrointestinal reactions were most frequently reported during dosage escalation.
None of the four labels gives a median number of days, a week count or a peak day. Any exact day-count you read elsewhere is therefore not a label finding. What the labels support is the shape: more reports around the escalation period, then a downward trend where the label states one.
The labels also do not say that nausea returns at every step. The table shows that rates differ by dose. Mounjaro nausea was 12%, 15% and 18% at 5, 10 and 15 mg, while Zepbound was 25%, 29% and 28%. The prescriber, not the reader, decides the dosing schedule.
What helps with Ozempic nausea?
The sources used here do not list a home remedy, so the steps below are about handling the pattern with your prescriber. Each point names where it comes from.
- Keep the schedule your prescriber set. The Ozempic and Wegovy labels link gastrointestinal reactions to dose escalation, and the prescriber decides any change. Never skip, delay or change a dose on your own.
- Rate it day by day. Writing nausea from 0 to 10 next to each dose date shows your own pattern. This is the article's suggestion, not a label instruction.
- Ask about food and fluids. Your prescriber or pharmacist can point you to what the patient leaflet says for your medicine.
- Give exact timing when you call. Say which medicine, which dose, and how many days after the shot the nausea began.
- Contact your prescriber if it does not ease. This is the article's general advice: nausea that persists is worth a call.
When should I worry about Ozempic nausea?
Nausea on Ozempic needs medical attention when it comes with persistent or severe abdominal pain. All four labels warn about acute pancreatitis: persistent or severe abdominal pain, sometimes radiating to the back, with or without nausea or vomiting. If it is suspected, the labels say to discontinue the medicine and seek care. Call your prescriber or emergency services right away rather than waiting.
Beyond the label's pancreatitis warning, the following is the article's general advice to contact your prescriber or seek care:
- Vomiting that does not stop.
- Signs of dehydration, such as being unable to keep fluids down.
- Nausea that is getting worse rather than easing.
- Any symptom that worries you.
Can Dose & Lose help you see your own nausea pattern?
Dose & Lose lets you log each dose and rate nausea from 0 to 10, day by day, then see the ratings over time next to your doses. That gives you a record to show your prescriber of when symptoms began after a shot or a dose step.
The app tracks and does not treat. It does not measure anything in your body, give dosing advice or predict nausea. Its medication-level view is an estimate drawn from the doses you log. You can read about the Dose & Lose app, for logging side effects day by day against doses.
Frequently asked questions
How long does Ozempic diarrhea last?
The Ozempic label gives no duration for diarrhea. It reports diarrhea in 8.5% of people on 0.5 mg and 8.8% on 1 mg, against 1.9% on placebo, and says most nausea, vomiting and diarrhea reports came during dose escalation. Persistent symptoms are worth raising with your prescriber, who decides what to do next.
Does nausea come back at every dose increase?
The labels do not say that nausea returns at every step. The Ozempic and Wegovy labels place most gastrointestinal reports in the dose-escalation period, which is when a step up falls. The Mounjaro and Zepbound labels add that events decreased over time. Your prescriber decides the schedule.
Can nausea on Ozempic last for months?
The labels give no figure for how long nausea can last, so no month count is a label finding. They say most events occurred during dose escalation, and the Mounjaro and Zepbound labels say events decreased over time. If nausea is still present and troubling, tell your prescriber rather than waiting.
Is nausea worse on Wegovy than on Ozempic?
The labels report higher nausea rates for Wegovy, but the trials are not like for like. Wegovy's weight-management trials found nausea in 44% on 2.4 mg against 16% on placebo. Ozempic's type 2 diabetes trials found 20.3% on 1 mg against 6.1%. Different populations and doses prevent a ranking.
Where do these figures come from?
Every rate and quotation above comes from the prescribing information on DailyMed.
- Ozempic prescribing information: nausea, vomiting and diarrhea by dose, timing note, pancreatitis warning.
- Wegovy prescribing information: weight-management rates and timing note.
- Mounjaro prescribing information: rates by dose and the "decreased over time" statement.
- Zepbound prescribing information: weight-management rates by dose and timing note.
Published by Petros IT Solutions SRL under the byline Dose & Lose Editorial Team. Corrections: office@doseandlose.com.